| Followers | 71 |
| Posts | 8989 |
| Boards Moderated | 0 |
| Alias Born | 03/06/2016 |
Friday, June 27, 2025 12:17:54 PM
2:40:52
but I'd like to reassure that we're not prioritising new applications over backlogged applications, so that we have written individually to all companies
2:41:04
with outstanding applications within the backlog recently and some of them,
2:41:12
a small number, have got major objections which do preclude approval at this stage
2:41:17
and they are going through CHM, our Commission on Human Medicines, and as soon as the outcome is clear from the CHM meeting, those will be communicated
2:41:28
to the respective companies. We have put in place new communication routes, so just looking at how do we communicate
2:41:36
and with additional resources in that vein to ensure much more transparent communication
but I'd like to reassure that we're not prioritising new applications over backlogged applications, so that we have written individually to all companies
2:41:04
with outstanding applications within the backlog recently and some of them,
2:41:12
a small number, have got major objections which do preclude approval at this stage
2:41:17
and they are going through CHM, our Commission on Human Medicines, and as soon as the outcome is clear from the CHM meeting, those will be communicated
2:41:28
to the respective companies. We have put in place new communication routes, so just looking at how do we communicate
2:41:36
and with additional resources in that vein to ensure much more transparent communication
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
